Cargando…
Jieduquyuzishen Prescription Attenuates Renal Fibrosis in MRL/lpr Mice via Inhibiting EMT and TGF-β1/Smad2/3 Pathway
Jieduquyuziyin prescription (JP) has been used to treat lupus nephritis (LN) and its effectiveness in the treatment of LN has been clinically proven, but the underlying mechanisms have yet to be completely understood. This aim of this study was to clarify the efficacy of JP on the epithelial-mesench...
Autores principales: | Wu, Shan, Ji, Lina, Fan, Xuemin, Fang, Sijia, Bao, Jie, Yuan, Xiao, Fan, Yongsheng, Xie, Guanqun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113882/ https://www.ncbi.nlm.nih.gov/pubmed/35591863 http://dx.doi.org/10.1155/2022/4987323 |
Ejemplares similares
-
Jieduquyuziyin Prescription Suppresses Inflammatory Activity of MRL/lpr Mice and Their Bone Marrow-Derived Macrophages via Inhibiting Expression of IRAK1-NF-κB Signaling Pathway
por: Ji, Lina, et al.
Publicado: (2020) -
Jieduquyuziyin Prescription-Treated Rat Serum Suppresses Activation of Peritoneal Macrophages in MRL/Lpr Lupus Mice by Inhibiting IRAK1 Signaling Pathway
por: Ji, Lina, et al.
Publicado: (2019) -
Investigating the Mechanisms of Jieduquyuziyin Prescription Improves Lupus Nephritis and Fibrosis via FXR in MRL/lpr Mice
por: Liu, Jingqun, et al.
Publicado: (2022) -
The Effects of Jieduquyuzishen Prescription-Treated Rat Serum on the BAFF/BAFF-R Signal Pathway
por: Wu, De-hong, et al.
Publicado: (2015) -
Self-Reactivity and the Expression of Memory Markers
Vary Independently in MRL-Mp+/+ and MRL-Mp-lpr/lpr
Mice
por: Smyth, Lesley, et al.
Publicado: (1992)